These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37175179)
1. Computer Analysis of the Inhibition of ACE2 by Flavonoids and Identification of Their Potential Antiviral Pharmacophore Site. Bogoyavlenskiy A; Alexyuk M; Alexyuk P; Berezin V; Almalki FA; Ben Hadda T; Alqahtani AM; Ahmed SA; Dall'Acqua S; Jamalis J Molecules; 2023 Apr; 28(9):. PubMed ID: 37175179 [TBL] [Abstract][Full Text] [Related]
2. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation. Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226 [TBL] [Abstract][Full Text] [Related]
3. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study. Shahbazi B; Mafakher L; Teimoori-Toolabi L J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180 [TBL] [Abstract][Full Text] [Related]
4. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2. Pokhrel S; Bouback TA; Samad A; Nur SM; Alam R; Abdullah-Al-Mamun M; Nain Z; Imon RR; Talukder MEK; Tareq MMI; Hossen MS; Karpiński TM; Ahammad F; Qadri I; Rahman MS Int J Biol Macromol; 2021 Nov; 191():1114-1125. PubMed ID: 34592225 [TBL] [Abstract][Full Text] [Related]
5. Petra/Osiris/Molinspiration and Molecular Docking Analyses of 3-Hydroxy-Indolin-2-one Derivatives as Potential Antiviral Agents. Hadda TB; Rastija V; AlMalki F; Titi A; Touzani R; Mabkhot YN; Khalid S; Zarrouk A; Siddiqui BS Curr Comput Aided Drug Des; 2021; 17(1):123-133. PubMed ID: 31878861 [TBL] [Abstract][Full Text] [Related]
6. How to face COVID-19: proposed treatments based on remdesivir and hydroxychloroquine in the presence of zinc sulfate. Docking/DFT/POM structural analysis. Ben Hadda T; Berredjem M; Almalki FA; Rastija V; Jamalis J; Emran TB; Abu-Izneid T; Esharkawy E; Rodriguez LC; Alqahtani AM J Biomol Struct Dyn; 2022; 40(19):9429-9442. PubMed ID: 34033727 [TBL] [Abstract][Full Text] [Related]
7. Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to Chalkha M; Nakkabi A; Hadda TB; Berredjem M; Moussaoui AE; Bakhouch M; Saadi M; Ammari LE; Almalki FA; Laaroussi H; Jevtovic V; Yazidi ME J Mol Struct; 2022 Nov; 1267():133605. PubMed ID: 35782312 [TBL] [Abstract][Full Text] [Related]
8. In silico evaluation of molecular interactions between macrocyclic inhibitors with the HCV NS3 protease. Docking and identification of antiviral pharmacophore site. Lafridi H; Almalki FA; Ben Hadda T; Berredjem M; Kawsar SMA; Alqahtani AM; Esharkawy ER; Lakhrissi B; Zgou H J Biomol Struct Dyn; 2023 Apr; 41(6):2260-2273. PubMed ID: 35075979 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, antimicrobial, molecular docking and molecular dynamics studies of lauroyl thymidine analogs against SARS-CoV-2: POM study and identification of the pharmacophore sites. Anowar Hosen M; Sultana Munia N; Al-Ghorbani M; Baashen M; Almalki FA; Ben Hadda T; Ali F; Mahmud S; Abu Saleh M; Laaroussi H; Kawsar SMA Bioorg Chem; 2022 Aug; 125():105850. PubMed ID: 35533581 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, antimicrobial, SAR, PASS, molecular docking, molecular dynamics and pharmacokinetics studies of 5'- Munia NS; Hosen MA; Azzam KMA; Al-Ghorbani M; Baashen M; Hossain MK; Ali F; Mahmud S; Shimu MSS; Almalki FA; Hadda TB; Laaroussi H; Naimi S; Kawsar SMA Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):1036-1083. PubMed ID: 35797068 [TBL] [Abstract][Full Text] [Related]
11. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents. Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269 [TBL] [Abstract][Full Text] [Related]
12. Potential SARS-CoV-2 RdRp inhibitors of cytidine derivatives: Molecular docking, molecular dynamic simulations, ADMET, and POM analyses for the identification of pharmacophore sites. M A Kawsar S; Hosen MA; Ahmad S; El Bakri Y; Laaroussi H; Ben Hadda T; Almalki FA; Ozeki Y; Goumri-Said S PLoS One; 2022; 17(11):e0273256. PubMed ID: 36441684 [TBL] [Abstract][Full Text] [Related]
13. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
14. Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study. Al-Shuhaib MBS; Hashim HO; Al-Shuhaib JMB Comput Biol Med; 2022 Feb; 141():105155. PubMed ID: 34942397 [TBL] [Abstract][Full Text] [Related]
15. Plant derived active compounds as potential anti SARS-CoV-2 agents: an Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, In Silico and POM Studies for the Identification of the Pharmacophore Sites of Benzylidene Derivatives. Hosen MI; Mukhrish YE; Jawhari AH; Celik I; Erol M; Abdallah EM; Al-Ghorbani M; Baashen M; Almalki FA; Laaroussi H; Hadda TB; Kawsar SMA Molecules; 2023 Mar; 28(6):. PubMed ID: 36985587 [TBL] [Abstract][Full Text] [Related]
17. DFT calculations and POM analyses of cytotoxicity of some flavonoids from aerial parts of Cupressus sempervirens: Docking and identification of pharmacophore sites. Elsharkawy ER; Almalki F; Ben Hadda T; Rastija V; Lafridi H; Zgou H Bioorg Chem; 2020 Jul; 100():103850. PubMed ID: 32460177 [TBL] [Abstract][Full Text] [Related]
18. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2. Mishra A; Rathore AS Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060 [TBL] [Abstract][Full Text] [Related]
19. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation. Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630 [TBL] [Abstract][Full Text] [Related]
20. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach. Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]